engages in the development and commercialization of life science instruments and related consumables used in the pharmaceutical and biotechnology industries worldwide.
It uses liquid handling, automation, and LabChip microfluidics technologies to create products for use in drug discovery and development, genomics and proteomics, and molecular diagnostics.
The company’s products include throughput screening systems; automated electrophoresis systems; liquid handlers; robotics; storage devices; dissolution, extraction, and evaporation workstations; and software that controls scheduling, integration, and data management.
The company also offers consumable and accessory products, such as LabChip devices, pipette tips, filters, glassware, and storage trays.
In addition, it provides other services, such as onsite validation of equipment, applications support, and assay development services, as well as product support services, including technical telephone support, field engineering support for emergency and preventative maintenance, field applications support, classroom training, repair depot, and loaner support.
The company sells its products through direct sales force, distributors, and original equipment manufacturers.
Caliper Life Sciences has collaboration agreements with Affymetrix, Inc.
to develop and provide automated target preparation instruments for Affymetrix’ commercialized microarray system, and its new high-throughput array system; Wako Pure Chemical Industries, Ltd.
to develop a new microfluidics-based instrument and chips designed for the immunodiagnostics market; and Bio-Rad Laboratories, Inc.
to develop and market a microfluidics instrument system.
Caliper was co-founded in 1995 by Michael R.
Knapp, J.
Wallace Parce, and Calvin Y.
H. Chow.
The company was formerly known as Caliper Technologies Corp.
and changed its name to Caliper Life Sciences, Inc.
in January 2004.
Caliper is headquartered in Hopkinton, Massachusetts.
